Concentration dependent plasma protein binding of salicylate in rheumatoid patients. 1979

R Ekstrand, and G Alvan, and O Borga

Acetylsalicylic acid in daily doses from 3 to 6g was prescribed to 8 patients with rheumatoid arthritis. Various assessments of clinical effect, as well as steady-state plasma concentrations and degree of plasma protein binding, were determined at each dose. The unbound fraction of salicylate increased with the dose, resulting in very high free concentrations of drug in some patients. No statistically significant relationship between total or unbound plasma concentration and the measurements of clinical efficacy were obtained. The marked increase with the dose in unbound salicylate concentration is interpreted as the result of the saturable elimination known to occur for this drug.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

R Ekstrand, and G Alvan, and O Borga
February 1984, British journal of rheumatology,
R Ekstrand, and G Alvan, and O Borga
November 1980, European journal of clinical pharmacology,
R Ekstrand, and G Alvan, and O Borga
September 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
R Ekstrand, and G Alvan, and O Borga
February 1979, Journal of pharmacokinetics and biopharmaceutics,
R Ekstrand, and G Alvan, and O Borga
April 1979, International journal of clinical pharmacology and biopharmacy,
R Ekstrand, and G Alvan, and O Borga
May 1981, Clinical pharmacology and therapeutics,
R Ekstrand, and G Alvan, and O Borga
October 1976, Clinical pharmacology and therapeutics,
R Ekstrand, and G Alvan, and O Borga
January 1987, European journal of clinical pharmacology,
R Ekstrand, and G Alvan, and O Borga
January 1985, European journal of clinical pharmacology,
R Ekstrand, and G Alvan, and O Borga
January 1984, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!